BiotechTube

Elagolix 200 MG + Leuprolide Acetate 3.75 MG/ML

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Infertility

Conditions

Infertility, Endometriosis

Trial Timeline

Sep 1, 2020 → Dec 30, 2024

NCT ID
NCT04445025

About Elagolix 200 MG + Leuprolide Acetate 3.75 MG/ML

Elagolix 200 MG + Leuprolide Acetate 3.75 MG/ML is a phase 1 stage product being developed by AbbVie for Infertility. The current trial status is completed. This product is registered under clinical trial identifier NCT04445025. Target conditions include Infertility, Endometriosis.

What happened to similar drugs?

16 of 20 similar drugs in Infertility were approved

Approved (16) Terminated (4) Active (4)
✅Crinone + DuphastonMerckApproved
✅FSHMerckApproved
✅CFA + rFSHMerckApproved
✅Gonal-f®MerckApproved
✅HCG + Lupron Trigger + Dual TriggerMerckApproved
✅GONAL f® prefilled pen + GONAL f® prefilled penMerckApproved
✅Gonal-f + Recombinant human chorionic gonadotrophin (r-hCG)MerckApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04445025Phase 1Completed

Competing Products

20 competing products in Infertility

See all competitors
ProductCompanyStageHype Score
GenSci094 + Placebo RecFSH / follitropin alfa + Biological: RecFSH / Follitropin alfa (Days 1 to 7) + Placebo GenSci094 + RecFSH / Follitropin alfa (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneSun PharmaceuticalPhase 3
40
Letrozole + Clomiphene citrateSun PharmaceuticalPhase 3
40
Corifollitropin Alfa + Follitropin beta + oral contraceptive pill pretreatment (Marvelon)MerckPhase 3
40
Crinone + DuphastonMerckApproved
35
Recombinant human follicle stimulating hormone (r-hFSH)MerckPre-clinical
26
hMG + Cetrorelix acetate + Coriogonadotropin alfa + Progesterone gelMerckPhase 3
47
Recombinant human luteinizing hormone (rhLH) + Recombinant follicle-stimulating hormone (rFSH)MerckPhase 2
27
FSHMerckApproved
43
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)MerckPhase 1/2
32
Pergoveris® + GONAL-f® + Recombinant human chorionic gonadotrophin (r-hCG)MerckPhase 3
40
CFA + rFSHMerckApproved
43
Micronised Progesterone + ProgesteroneMerckPhase 3
40
AS900672-Enriched 50 microgram (mcg) + AS900672-Enriched 100 mcg + AS900672-Enriched 150 mcg + Follitropin alfa 150 international unit (IU) + Recombinant human chorionic gonadotropin (r-hCG)MerckPhase 2
35
gonadotropins plus GnRH antagonists + ganirelixMerckPre-clinical
26
ELONVA + PUREGONMerckPre-clinical
26
Gonalef® (Follitropin alfa) + Purified pituitary gonadotropin (Fertinorm-P®)MerckPhase 3
40
EstrogensMerckPhase 3
40
r-hFSH + r-hLH + u-hCGMerckPhase 2
35
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)MerckPhase 1/2
32
Gonal-f®MerckApproved
35